180 related articles for article (PubMed ID: 16536918)
1. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists.
Dhillo WS; Jayasena CN; Lewis CJ; Martin NM; Tang KC; Meeran K; Todd JF
Ann Clin Biochem; 2006 Mar; 43(Pt 2):153-5. PubMed ID: 16536918
[TBL] [Abstract][Full Text] [Related]
2. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
[TBL] [Abstract][Full Text] [Related]
3. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
5. Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy.
Dhillo WS; Jayasena CN; Jackson JE; Lynn JA; Bloom SR; Meeran K; Todd JF
Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):429-33. PubMed ID: 15756095
[TBL] [Abstract][Full Text] [Related]
6. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
7. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?
Mallow S; Rebuck JA; Osler T; Ahern J; Healey MA; Rogers FB
Curr Surg; 2004; 61(5):452-8. PubMed ID: 15475094
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
9. Zollinger-Ellison syndrome: methods of diagnosis and treatment.
Sarin RR; Sangal AK; Schubert TT; Rival J
Henry Ford Hosp Med J; 1990; 38(1):48-51. PubMed ID: 1977726
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal contact granuloma.
Wani MK; Woodson GE
Laryngoscope; 1999 Oct; 109(10):1589-93. PubMed ID: 10522926
[TBL] [Abstract][Full Text] [Related]
11. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Bailie GR; Mason NA; Elder SJ; Andreucci VE; Greenwood RN; Akiba T; Saito A; Bragg-Gresham JL; Gillespie BW; Young EW
Hemodial Int; 2006 Apr; 10(2):180-8. PubMed ID: 16623672
[TBL] [Abstract][Full Text] [Related]
12. False-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy.
Goldman JA; Blanton WP; Hay DW; Wolfe MM
Clin Gastroenterol Hepatol; 2009 May; 7(5):600-2. PubMed ID: 19245850
[TBL] [Abstract][Full Text] [Related]
13. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
14. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.
Valuck RJ; Ruscin JM
J Clin Epidemiol; 2004 Apr; 57(4):422-8. PubMed ID: 15135846
[TBL] [Abstract][Full Text] [Related]
15. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
[TBL] [Abstract][Full Text] [Related]
17. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.
Merchant SH; VanderJagt T; Lathrop S; Amin MB
Am J Surg Pathol; 2006 Dec; 30(12):1581-7. PubMed ID: 17122515
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
